Zidovudine and Lamivudine Given Once Versus Twice Daily
NCT00014014
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
NIH
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Lamivudine/Zidovudine
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
[object Object]